199 related articles for article (PubMed ID: 29186710)
1. ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling.
Chen L; Tang J; Feng Y; Li S; Xiang Q; He X; Ren G; Peng W; Xiang T
Cell Physiol Biochem; 2017; 44(4):1370-1380. PubMed ID: 29186710
[TBL] [Abstract][Full Text] [Related]
2. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma.
Peng L; Yang Z; Tan C; Ren G; Chen J
Mol Med Rep; 2013 Mar; 7(3):1055-61. PubMed ID: 23358566
[TBL] [Abstract][Full Text] [Related]
5. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
7. High-resolution melting analysis of ADAMTS9 methylation levels in gastric, colorectal, and pancreatic cancers.
Zhang C; Shao Y; Zhang W; Wu Q; Yang H; Zhong Q; Zhang J; Guan M; Yu B; Wan J
Cancer Genet Cytogenet; 2010 Jan; 196(1):38-44. PubMed ID: 19963134
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ADAMTS9-AS1, as prognostic marker, promotes cell proliferation and EMT in colorectal cancer.
Chen W; Tu Q; Yu L; Xu Y; Yu G; Jia B; Cheng Y; Wang Y
Hum Cell; 2020 Oct; 33(4):1133-1141. PubMed ID: 32918700
[TBL] [Abstract][Full Text] [Related]
9. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019
[TBL] [Abstract][Full Text] [Related]
10. The phosphoinositide hydrolase phospholipase C delta1 inhibits epithelial-mesenchymal transition and is silenced in colorectal cancer.
Xiang Q; He X; Mu J; Mu H; Zhou D; Tang J; Xiao Q; Jiang Y; Ren G; Xiang T; Peng W
J Cell Physiol; 2019 Aug; 234(8):13906-13916. PubMed ID: 30618183
[TBL] [Abstract][Full Text] [Related]
11. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
Zhong G; Li H; Shan T; Zhang N
Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
[TBL] [Abstract][Full Text] [Related]
12. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
13. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
14. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers.
Hu X; Sui X; Li L; Huang X; Rong R; Su X; Shi Q; Mo L; Shu X; Kuang Y; Tao Q; He C
J Pathol; 2013 Jan; 229(1):62-73. PubMed ID: 22926751
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
17. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
[TBL] [Abstract][Full Text] [Related]
19. Expression of circZNF609 is Down-Regulated in Colorectal Cancer Tissue and Promotes Apoptosis in Colorectal Cancer Cells by Upregulating p53.
Zhang X; Zhao Y; Kong P; Han M; Li B
Med Sci Monit; 2019 Aug; 25():5977-5985. PubMed ID: 31401644
[TBL] [Abstract][Full Text] [Related]
20. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
